Brivanib alaninate 5mg 5mg | Purity Not Available
Adooq Bioscience
Brivanib alaninate (BMS-582664) is a dual tyrosine kinase inhibitor of VEGFR and FGFR signaling.
More Information Supplier PageBrivanib alaninate (BMS-582664) is a dual tyrosine kinase inhibitor of VEGFR and FGFR signaling.
More Information Supplier PageBrivanib alaninate (BMS-582664) is a dual tyrosine kinase inhibitor of VEGFR and FGFR signaling.
More Information Supplier PageBrivanib alaninate (BMS-582664) is a dual tyrosine kinase inhibitor of VEGFR and FGFR signaling.
More Information Supplier PageBMS-708163 is an oral gamma secretase inhibitor designed for selective inhibition of amyloid beta synthesis.
More Information Supplier PageBMS-708163 is an oral gamma secretase inhibitor designed for selective inhibition of amyloid beta synthesis.
More Information Supplier PageBMS-708163 is an oral gamma secretase inhibitor designed for selective inhibition of amyloid beta synthesis.
More Information Supplier PageBMS-707035 is an HIV-1 integrase (IN) inhibitor. HIV-1 integrase (IN) represents a therapeutically advantageous viral target to treat HIV/AIDS in the clinic.
More Information Supplier PageBMS-707035 is an HIV-1 integrase (IN) inhibitor. HIV-1 integrase (IN) represents a therapeutically advantageous viral target to treat HIV/AIDS in the clinic.
More Information Supplier PageBMS-707035 is an HIV-1 integrase (IN) inhibitor. HIV-1 integrase (IN) represents a therapeutically advantageous viral target to treat HIV/AIDS in the clinic.
More Information Supplier PageBMS-707035 is an HIV-1 integrase (IN) inhibitor. HIV-1 integrase (IN) represents a therapeutically advantageous viral target to treat HIV/AIDS in the clinic.
More Information Supplier Page